HLN:NYSE
Haleon PLC - ADR
$9.18
arrow_downward
-0.49%(-0.045) 1D
Sep 10, 11:05:43 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLN...
Open
$9.21
High
$9.26
Low
$9.17
Mkt. cap
40.02B
Avg. vol.
10.33M
Volume
9.39M
Dividend
2.14%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
18.77
52-wk high
$11.28
52-wk low
$8.65
EPS
$0.49
Beta
0.13
Shares outstanding
4.40B
No. of employees
25K
Open
$9.21
High
$9.26
Low
$9.17
Mkt. cap
40.02B
Avg. vol.
10.33M
Volume
9.39M
Dividend
2.14%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
18.77
52-wk high
$11.28
52-wk low
$8.65
EPS
$0.49
Beta
0.13
Shares outstanding
4.40B
No. of employees
25K
News stories
From web sources and news partners
ad-hoc-news.de
·
23 hours ago
Haleon stock dips as Deutsche Bank cuts target for consumer-health group
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC - ADR